VALIANTLAB logo

Valiant Laboratories Limited Stock Price

NSEI:VALIANTLAB Community·₹3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VALIANTLAB Share Price Performance

₹57.19
-34.42 (-37.57%)
₹57.19
-34.42 (-37.57%)
Price ₹57.19

VALIANTLAB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
0 Rewards

Valiant Laboratories Limited Key Details

₹2.0b

Revenue

₹1.7b

Cost of Revenue

₹295.7m

Gross Profit

₹339.1m

Other Expenses

-₹43.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
-0.80
14.55%
-2.13%
16.9%
View Full Analysis

About VALIANTLAB

Founded
1980
Employees
79
CEO
Santosh Vora
WebsiteView website
valiantlabs.in

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Recent VALIANTLAB News & Updates

Recent updates

No updates